EMBOCEPT Trademark
Serial Number: 79200744 • Registration: 5215890
EMBOCEPT is a trademark filed by
PharmaCept GmbH
on October 18, 2016. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Max Moskowitz OSTROLENK FABER LLP
845 THIRD AVENUE, 8th Floor
New York, NY 10022
UNITED STATES
Trademark Details
Filing Date
October 18, 2016
Registration Date
June 6, 2017
Published for Opposition
March 21, 2017
Goods & Services
Pharmaceutical preparations, namely, embolisates
Filing History
NEW REPRESENTATIVE AT IB RECEIVED
Sep 25, 2025 NREP
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Feb 4, 2024 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Feb 4, 2024 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 4, 2024 APRE
TEAS SECTION 71 & 15 RECEIVED
May 31, 2023 ES75
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Apr 28, 2022 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
Mar 20, 2022 CRCV
NEW REPRESENTATIVE AT IB RECEIVED
Mar 11, 2022 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Mar 4, 2022 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Nov 12, 2021 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Mar 20, 2020 NREP
NOTIFICATION PROCESSED BY IB
Jul 28, 2017 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Jul 7, 2017 FICS
FINAL DISPOSITION PROCESSED
Jul 7, 2017 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Jul 6, 2017 GPAR
REGISTERED-PRINCIPAL REGISTER
Jun 6, 2017 R.PR
NOTIFICATION PROCESSED BY IB
Mar 25, 2017 GPNX
PUBLISHED FOR OPPOSITION
Mar 21, 2017 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 8, 2017 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 8, 2017 OP2R
NOTICE OF PUBLICATION
Mar 1, 2017 NPUB
APPLICATION FILING RECEIPT MAILED
Feb 10, 2017 MAFR
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 8, 2017 CNSA
ASSIGNED TO EXAMINER
Feb 6, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 6, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 2, 2017 REPR
